With Democrat In White House, 'More Aggressive' FDA Comes into Focus

摘要

Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus.With bigger majorities in both chambers of Congress, Democrats' preference for more pre-market regulation and post-market enforcement of food and drug products will be imposed on FDA, according to food and drug attorney John Manthei, a former House Committee on Energy and Commerce majority counsel.